Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
AbCellera Biologics Inc. (ABCL) had Receiveable Turnover of 0.86 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$28.83M |
|
$-162.86M |
|
-- |
|
$28.83M |
|
$343.60M |
|
$-314.77M |
|
$114.37M |
|
$-200.40M |
|
$-200.40M |
|
$-162.86M |
|
$-162.86M |
|
$-162.86M |
|
$-162.86M |
|
$-314.77M |
|
$-217.77M |
|
294.33M |
|
294.33M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$751.37M |
|
$340.43M |
|
$609.18M |
|
$1.36B |
|
$76.61M |
|
-- |
|
$227.86M |
|
$304.47M |
|
$1.06B |
|
$966.16M |
|
$1.06B |
|
295.76M |
|
| Cash Flow Statement Financials | |
$-108.56M |
|
$121.41M |
|
$12.77M |
|
$160.61M |
|
$183.62M |
|
$23.00M |
|
$67.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1091.69% |
|
-1091.69% |
|
-755.27% |
|
-695.02% |
|
-564.83% |
|
$-186.95M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
|
Receiveable Turnover |
0.86 |
425.55 |
|
-15.42% |
|
-16.86% |
|
-11.97% |
|
-15.42% |
|
$3.57 |
|
$-0.64 |
|
$-0.37 |
|